Here’s yet another exhibit for the jury to consider in the case of Sanity v. Sell-Side Research: Ladies and Gentlemen, I present Barclays Bank on Amylin Pharmaceuticals: Firm is introducing long term estimates for AMLN from 2011-2020 which assume exenatide LAR approval and launch in the US by 3Q10 and by 3Q11 in Europe. In…